Neurones Statistics
Total Valuation
Neurones has a market cap or net worth of EUR 841.24 million. The enterprise value is 654.48 million.
| Market Cap | 841.24M |
| Enterprise Value | 654.48M |
Important Dates
The last earnings date was Wednesday, March 11, 2026.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | Jun 11, 2025 |
Share Statistics
Neurones has 24.31 million shares outstanding.
| Current Share Class | 24.31M |
| Shares Outstanding | 24.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.41% |
| Owned by Institutions (%) | 6.98% |
| Float | 12.07M |
Valuation Ratios
The trailing PE ratio is 16.15 and the forward PE ratio is 14.71.
| PE Ratio | 16.15 |
| Forward PE | 14.71 |
| PS Ratio | 0.98 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.56 |
| EV / Sales | 0.76 |
| EV / EBITDA | 7.73 |
| EV / EBIT | 8.66 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 59.63% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | 119,254 |
| Profits Per Employee | 7,248 |
| Employee Count | 7,188 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Neurones has paid 23.20 million in taxes.
| Income Tax | 23.20M |
| Effective Tax Rate | 27.26% |
Stock Price Statistics
The stock price has decreased by -27.16% in the last 52 weeks. The beta is 0.49, so Neurones's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -27.16% |
| 50-Day Moving Average | 38.11 |
| 200-Day Moving Average | 41.36 |
| Relative Strength Index (RSI) | 41.98 |
| Average Volume (20 Days) | 15,830 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neurones had revenue of EUR 857.20 million and earned 52.10 million in profits.
| Revenue | 857.20M |
| Gross Profit | 857.20M |
| Operating Income | 75.60M |
| Pretax Income | 85.10M |
| Net Income | 52.10M |
| EBITDA | 84.69M |
| EBIT | 75.60M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 8.82% and 6.08%.
| Gross Margin | 100.00% |
| Operating Margin | 8.82% |
| Pretax Margin | 9.93% |
| Profit Margin | 6.08% |
| EBITDA Margin | 9.88% |
| EBIT Margin | 8.82% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 4.05%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 4.05% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 4.05% |
| Earnings Yield | 6.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |